Cardio Oncology Cardiovascular Disease Research 
Circulation
MARCH 19, 2025
The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors. Circulation, Ahead of Print.
DAIC
JUNE 19, 2024
Getty Images milla1cf Wed, 06/19/2024 - 20:54 June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. The new study was motivated by a need to fill that gap, Rao said. They found that exposure to PM2.5,
DAIC
FEBRUARY 2, 2024
The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held in Washington, D.C., Cardio-Oncology Educational Training: What Do I Need to Learn? 9-11, 2024. 9-11, 2024, with program planners preparing a robust program. How to Structure?:
Heart BMJ
NOVEMBER 27, 2023
The number of patients at the intersection of cancer and cardiovascular disease (CVD) is increasing, reflecting ageing global populations, rising burden of shared cardiometabolic risk factors, and improved cancer survival. There is need for development of a stronger evidence base to guide clinical practice in cardio-oncology.
Frontiers in Cardiovascular Medicine
JUNE 6, 2024
Cardio-oncology is a new field of interest in cardiology focusing on the detection and treatment of cardiovascular diseases, such as arrhythmias, myocarditis, and heart failure, as side-effects of chemotherapy and radiotherapy.
Cardiology Update
APRIL 9, 2024
Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary superiority endpoint was clinically relevant bleeding (Bleeding Academic Research Consortium [known as BARC] types 2, 3, or 5). New Engl J Med. April 6, 2024.
Expert insights. Personalized for you.
55 
Let's personalize your content